The European Pharmacopoeia (Ph. Eur.) Monograph 0478 ( ) defines mandatory quality standards, including tests for uniformity, disintegration, and dissolution, to ensure the safety and efficacy of tablets intended for oral administration. Covering various forms, from conventional to modified-release, it mandates specific, rigorous quality control tests to ensure compliance. For a detailed overview, review the ECA Academy article on the topic.
- Uncoated tablets
- Coated tablets (film-coated, sugar-coated)
- Modified-release tablets (prolonged, delayed, pulsatile)
- Soluble tablets (must dissolve in water within a specific time)
- Dispersible tablets (uniform dispersion in water)
- Orodispersible tablets (disintegrate in oral cavity within 3 minutes)
- Requires the completion of an A and B identification test. Usually A is chromatographic (e.g., HPLC retention time match) and B is a confirmatory test (e.g., UV spectrum or chemical reaction). This is robust and meets regulatory expectations.
- Explicitly defines tablets as solid dosage forms containing a single dose of one or more active substances. It distinguishes between uncoated, film-coated, and non-functional coated tablets (excluding sugar-coated – see Chapter 2.9.1).
- Provides a helpful list of common excipients (diluents, binders, disintegrants, glidants, lubricants).
- Appropriate primary/secondary packaging to maintain product quality; label must state batch number, expiry, storage conditions, and dosing instructions.
- Specification to demonstrate release characteristics; method (apparatus, medium, rpm/temperature) either as stated in product monograph or selected and justified by the manufacturer. Acceptance criteria tied to percent release at specified timepoints.
The monograph outlines several mandatory tests that assess both physical integrity and chemical uniformity: European Pharmacopoeia - Background and Mission
News
